Olga Golubnitschaja, Kamil Biringer, Peter Kubatka, Peter Kruzliak, Denis Baranenko, Elmira Eminova, Robert Prosecky, Mariusz Adamek, Martin Caprnda, Ludovit Gaspar, Alena Mazurakova, Dietrich Büsselberg, Martin Kello, Martin Pec, Martin Jozef Pec, Terezia Pribulova, Jana Sivakova, Erik Kudela, Marek Samec, Lenka Koklesova
Journal: Pregnancy hypertension 2022;29():72-85
PMID: 35803199
Hypertensive disorders in pregnancy represent severe complications of pregnancy, which, if not treated, can result in serious health consequences for the mother and the child. Flavonoids are bioactive secondary metabolites commonly found in fruits, vegetables, green tea, whole grains, and medicinal plants. Flavonoids exert potent protective efficacy in experimental models of hypertensive disorders in pregnancy, especially preeclampsia, demonstrated through their capacity to modulate inflammatory responses, oxidative stress, and vascular dysfunction. In addition to their potential as therapeutics, flavonoids or flavonoid-rich food could be helpful to decrease the risk of hypertensive disorders in pregnancy when included in the diet pattern before and during pregnancy. However, the clinical evaluation of the potential capacity of flavonoids in hypertensive disorders in pregnancy is insufficient. Due to promising results from experimental studies, we highlight the need for the evaluation of flavonoids also in an appropriate clinical setting, which can be, together with proper preventive strategies, helpful in the overall management of hypertensive disorders in pregnancy.
Copyright © 2022. Published by Elsevier B.V.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.